Steward Partners Investment Advisory’s Neurotrope, Inc. Common NTRP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,491
Closed -$1K 3546
2020
Q4
$1K Sell
1,491
-1,407
-49% -$1.46K ﹤0.01% 2854
2020
Q3
$3K Hold
2,898
﹤0.01% 2547
2020
Q2
$3K Hold
2,898
﹤0.01% 2449
2020
Q1
$2K Hold
2,898
﹤0.01% 2346
2019
Q4
$2K Hold
2,898
﹤0.01% 2468
2019
Q3
$2K Hold
2,898
﹤0.01% 2479
2019
Q2
$23K Buy
+2,898
New +$19.5K ﹤0.01% 1664

Steward Partners Investment Advisory's NTRP Position: Q1 2021 in Review

Steward Partners Investment Advisory sold out of Neurotrope, Inc. Common (NTRP) in Q1 2021, closing a stake of 1,491 shares — an estimated $1K sold.

Steward Partners Investment Advisory first reported a position in NTRP in Q2 2019 and held it in 7 quarters. The position peaked at $23K in Q2 2019. 0 funds tracked by Wall St. Rank hold NTRP as of Q1 2021.

  • Steward Partners Investment Advisory reported no remaining Neurotrope, Inc. Common position as of Q1 2021 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 1,491 Neurotrope, Inc. Common shares in Q1 2021, an estimated $1K.
  • Steward Partners Investment Advisory first reported a position in Neurotrope, Inc. Common in Q2 2019 and held it in 7 quarters.
  • Steward Partners Investment Advisory's Neurotrope, Inc. Common position peaked at $23K in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q1 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2021, filed 14 May 2021.